Brief: Lavipharm Q3 net loss widens to EUR 2.7 million

Lavipharm SA

30/11/2015 15:41

Nov 30 (Reuters) - Lavipharm SA  LPHr.AT : 
    * Q3 turnover 5.7 million euro ($6.02 million) versus 7.4 
million euro year ago 
    * Q3 EBITDA 784,000 euro versus 1.6 million euro year ago 
    * Net cash on Sept. 30, 2.0 million euro versus 2.1 million 
euro year ago 
    * Q3 net loss 2.7 million euro versus loss 1.4 million euro 
year ago 
 
Source text: http://bit.ly/1Q8vjTI 
Further company coverage:  LPHr.AT  
 
($1 = 0.9464 euros) 
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 698 3920;))